title: Response to imatinib in patient with corticosteroid-unresponsive idiopathic hypereosinophilic syndrome.
authors.affiliation: Erciyes University School of Medicine, Department of Chest Diseases, Division of Immunology and Allergy, Kayseri, Turkey. Electronic address: insu2004@yahoo.com.
authors.forename: I
authors.initials: I
authors.lastname: Yilmaz
authors.affiliation: Erciyes University School of Medicine, Department of Internal Medicine, Division of Hematology, Turkey.
authors.forename: L
authors.initials: L
authors.lastname: Kaynar
authors.affiliation: Erciyes University School of Medicine, Department of Chest Diseases, Turkey.
authors.forename: N
authors.initials: N
authors.lastname: Tutar
authors.affiliation: Erciyes University School of Medicine, Department of Internal Medicine, Division of Hematology, Turkey.
authors.forename: C
authors.initials: C
authors.lastname: Pala
authors.affiliation: Erciyes University School of Medicine, Department of Pathology, Turkey.
authors.forename: O
authors.initials: O
authors.lastname: Canoz
authors.affiliation: Erciyes University School of Medicine, Department of Chest Diseases, Turkey.
authors.forename: H
authors.initials: H
authors.lastname: Buyukoglan
authors.affiliation: Erciyes University School of Medicine, Department of Chest Diseases, Turkey.
authors.forename: I
authors.initials: I
authors.lastname: Gulmez
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy*; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000068877:Imatinib Mesylate